FDA Approves FoundationOne Liquid CDx Liquid Biopsy Test
Foundation Medicine’s FoundationOne Liquid CDx is a pan-tumor liquid biopsy test for patients with solid tumors.
Read More
Search Results for: prostate cancer
Advances in Liquid Biopsy
Mastering tumor heterogeneity to unlock personalized medicine
Read MoremiR Scientific Introduces Sentinel Disease Management Platform
The Sentinel disease management platform incorporates a number of noninvasive liquid biopsy urine tests that can help accurately detect, score, and monitor urological cancers.
Read More
Paige and Philips to Bring AI to Clinical Pathology Diagnostics
AI-based cancer assessment tools are poised to help pathologists improve the speed and accuracy of cancer diagnostics, ultimately leading to better patient care.
Read More
Enrichment of Human Carcinoma Cells for Molecular Analysis
The FFPE Tissue Dissociation kit from Miltenyi Biotec offers a standardized protocol for the dissociation of carcinoma samples prior to the enrichment of carcinoma tumor cells for molecular analysis.
Read More